Boehringer Ingelheim Pharmaceuticals, Inc. announced today that STIOLTO™ RESPIMAT ® (tiotropium bromide and olodaterol) Inhalation Spray is now available by prescription at pharmacies across the ...
In addition to the new exacerbation data, the indication for Stiolto Respimat has been revised. The Food and Drug Administration (FDA) has approved updated labeling for Stiolto Respimat (tiotropium ...
Boehringer Ingelheim’s sales of chronic obstructive pulmonary disease drugs may be flagging, but they still remain substantial and require millions of inhalers to deliver them. To provide for that, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results